Advertisement

Topics

Eisai to present new data for lenvatinib in hepatocellular carcinoma and renal cell carcinoma at ESMO 2017 Congress

07:13 EDT 4 Sep 2017 | FinanzNachrichten

HATFIELD, England, September 4, 2017 /PRNewswire/ -- FOR EMEAMEDICALMEDIA ONLY: NOT FOR AUSTRIAN/SWISS MEDIA Health-related quality of life analysis of Phase III data for lenvatinib vs sorafenib i...

Original Article: Eisai to present new data for lenvatinib in hepatocellular carcinoma and renal cell carcinoma at ESMO 2017 Congress

NEXT ARTICLE

More From BioPortfolio on "Eisai to present new data for lenvatinib in hepatocellular carcinoma and renal cell carcinoma at ESMO 2017 Congress"

Quick Search
Advertisement
 

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...